Inovalon Enters Next Chapter of Innovation and Transformation Led by New CEO, Adam Kansler
Inovalon, a cloud-based healthcare software solutions provider, has appointed Adam Kansler as its new Chief Executive Officer, effective March 2. Kansler succeeds founder Keith Dunleavy, M.D., bringing 30 years of executive experience to the role.
The leadership transition follows Inovalon's privatization in November 2021 and its three-year transformation into a pure-play cloud-based SaaS and DaaS platform company. Kansler previously served as President of S&P Global Market Intelligence, where he managed a $4.5 billion revenue division with 18,000 team members.
During his tenure at S&P Global, Kansler led the development of new software and data products, launched multiple GenAI-driven solutions, executed successful acquisitions, and established the company's Enterprise Data executive function. At Inovalon, he will focus on advancing the company's mission of empowering data-driven healthcare to improve outcomes and economics for its more than 50,000 customers.
Inovalon, un fornitore di soluzioni software per la sanità basato su cloud, ha nominato Adam Kansler come nuovo Amministratore Delegato, con effetto dal 2 marzo. Kansler succede al fondatore Keith Dunleavy, M.D., portando con sé 30 anni di esperienza dirigenziale.
Il passaggio di leadership segue la privatizzazione di Inovalon avvenuta a novembre 2021 e la sua trasformazione triennale in una società puramente basata su piattaforme SaaS e DaaS. Kansler ha precedentemente ricoperto il ruolo di Presidente di S&P Global Market Intelligence, dove ha gestito una divisione con ricavi di 4,5 miliardi di dollari e 18.000 membri del team.
Durante la sua permanenza in S&P Global, Kansler ha guidato lo sviluppo di nuovi software e prodotti di dati, lanciato diverse soluzioni basate su GenAI, eseguito acquisizioni di successo e istituito la funzione esecutiva di Enterprise Data dell'azienda. In Inovalon, si concentrerà sul progresso della missione dell'azienda di potenziare la sanità basata sui dati per migliorare i risultati e l'economia per i suoi oltre 50.000 clienti.
Inovalon, un proveedor de soluciones de software de salud basado en la nube, ha nombrado a Adam Kansler como su nuevo Director Ejecutivo, con efecto a partir del 2 de marzo. Kansler sucede al fundador Keith Dunleavy, M.D., aportando 30 años de experiencia ejecutiva al cargo.
La transición de liderazgo sigue a la privatización de Inovalon en noviembre de 2021 y su transformación de tres años en una compañía pura de plataformas SaaS y DaaS. Kansler anteriormente se desempeñó como Presidente de S&P Global Market Intelligence, donde gestionó una división con ingresos de 4.5 mil millones de dólares y 18,000 miembros del equipo.
Durante su tiempo en S&P Global, Kansler lideró el desarrollo de nuevos software y productos de datos, lanzó múltiples soluciones impulsadas por GenAI, ejecutó adquisiciones exitosas y estableció la función ejecutiva de Enterprise Data de la empresa. En Inovalon, se centrará en avanzar en la misión de la empresa de empoderar la atención médica basada en datos para mejorar los resultados y la economía para sus más de 50,000 clientes.
Inovalon은 클라우드 기반의 헬스케어 소프트웨어 솔루션 제공업체로, Adam Kansler를 새로운 최고 경영자(CEO)로 임명했습니다. 이 임명은 3월 2일부터 시행됩니다. Kansler는 창립자인 Keith Dunleavy, M.D.를 이어받으며, 30년의 경영 경험을 가지고 있습니다.
리더십 전환은 2021년 11월 Inovalon이 민영화된 이후, SaaS 및 DaaS 플랫폼 회사로의 3년 변화를 뒤따릅니다. Kansler는 이전에 S&P Global Market Intelligence의 사장으로 재직하며 450억 달러의 수익을 올리는 부서를 관리했습니다. 이 부서에는 18,000명의 팀원이 포함되어 있습니다.
S&P Global 재직 중, Kansler는 새로운 소프트웨어 및 데이터 제품의 개발을 이끌었고, 여러 GenAI 기반 솔루션을 출시했으며, 성공적인 인수를 실행하고, 회사의 Enterprise Data 경영 기능을 설립했습니다. Inovalon에서는 데이터 기반 헬스케어를 통해 결과와 경제성을 개선하는 회사의 사명을 발전시키는 데 집중할 것입니다.
Inovalon, un fournisseur de solutions logicielles de santé basé sur le cloud, a nommé Adam Kansler comme nouveau Directeur Général, prenant effet le 2 mars. Kansler succède au fondateur Keith Dunleavy, M.D., apportant 30 ans d'expérience exécutive à ce poste.
La transition de leadership fait suite à la privatisation d'Inovalon en novembre 2021 et à sa transformation de trois ans en une entreprise de plateforme SaaS et DaaS pure. Kansler a précédemment été Président de S&P Global Market Intelligence, où il a géré une division avec un chiffre d'affaires de 4,5 milliards de dollars et 18 000 membres d'équipe.
Au cours de son mandat chez S&P Global, Kansler a dirigé le développement de nouveaux logiciels et produits de données, lancé plusieurs solutions alimentées par GenAI, réalisé des acquisitions réussies et établi la fonction exécutive Enterprise Data de l'entreprise. Chez Inovalon, il se concentrera sur l'avancement de la mission de l'entreprise visant à renforcer les soins de santé basés sur les données pour améliorer les résultats et l'économie pour ses plus de 50 000 clients.
Inovalon, ein Anbieter von cloudbasierten Softwarelösungen im Gesundheitswesen, hat Adam Kansler als neuen Chief Executive Officer ernannt, der am 2. März in Kraft tritt. Kansler folgt dem Gründer Keith Dunleavy, M.D., und bringt 30 Jahre Führungserfahrung in die Rolle ein.
Der Führungswechsel erfolgt nach der Privatisierung von Inovalon im November 2021 und der dreijährigen Transformation des Unternehmens zu einer reinen SaaS- und DaaS-Plattformgesellschaft. Zuvor war Kansler Präsident von S&P Global Market Intelligence, wo er eine Division mit einem Umsatz von 4,5 Milliarden Dollar und 18.000 Teammitgliedern leitete.
Während seiner Zeit bei S&P Global leitete Kansler die Entwicklung neuer Software- und Datenprodukte, lancierte mehrere GenAI-gesteuerte Lösungen, führte erfolgreiche Übernahmen durch und etablierte die Unternehmensfunktion für Enterprise Data. Bei Inovalon wird er sich darauf konzentrieren, die Mission des Unternehmens zu fördern, datengestützte Gesundheitsversorgung zu ermöglichen, um die Ergebnisse und die Wirtschaftlichkeit für mehr als 50.000 Kunden zu verbessern.
- Appointment of experienced CEO with proven track record in data and technology
- Successfully completed transformation to pure-play cloud-based SaaS/DaaS platform
- Large customer base of 50,000+ clients
- New CEO brings expertise in GenAI solutions and cloud operations
- Recent privatization may limit public market access and transparency
- Leadership transition period could create temporary operational uncertainties
New Leadership, Same Mission: Advancing Data-Driven Healthcare to Improve Outcomes and Economics
Inovalon was founded by Keith Dunleavy, M.D., with a desire to apply the power of data to the improvement of healthcare’s outcomes and economics — a mission the company remains committed to today. Following the company’s privatization in November 2021 and its recently completed three-year transformation to become a pure-play cloud-based SaaS and DaaS platform company, Inovalon is proud to embark on its next chapter with Kansler, succeeding Dunleavy, who has served as CEO since its founding.
“I am excited to build on the company’s strong foundation and momentum in the healthcare space,” said Adam Kansler, Chief Executive Officer of Inovalon. “It’s inspiring to lead a team that is dedicated to empowering customers with data to achieve better outcomes and economics —there is a real-world impact of what we do for the industry that reaches all corners of the healthcare ecosystem — from our more than 50,000 customers to all the families and individuals they serve.”
Eron Kelly, President of Inovalon, said, “Adam is an exceptional leader who is primed to bring his experience leading data-centric business and tech innovation at large scale to continue the advancement of Inovalon’s mission. He is a leader who prioritizes the customer, focusing on how we can support their ability to serve others. I look forward to working closely with him to bring our company through its next growth stage and beyond.”
Prior to Inovalon, Kansler served as President of S&P Global Market Intelligence, the
To stay up to date on the latest innovations and insights from Inovalon, visit www.inovalon.com/our-company/news/.
About Inovalon
Inovalon is a leading provider of cloud-based SaaS solutions empowering data-driven healthcare. The Inovalon ONE® Platform brings together national-scale connectivity, real-time primary source data access, and advanced analytics into a sophisticated cloud-based platform empowering improved outcomes and economics across the healthcare ecosystem. The company’s analytics and capabilities are used by over 50,000 active, licensed customers, and are informed by the primary source data of more than 87 billion medical events across 1.1 million physicians, 687,000 clinical settings, and 399 million unique lives. For more information, visit www.inovalon.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250304034994/en/
Tom Paolella
Sr. Director, Press and Analyst Relations, Inovalon
Thomas.paolella@inovalon.com
Source: Inovalon
FAQ
Who is the new CEO of Inovalon and when did they take over?
What was Adam Kansler's previous role before joining Inovalon?
What major transformations has Inovalon undergone recently?
What is Inovalon's current market reach in healthcare?
What key achievements did Kansler accomplish at S&P Global (SPGI)?
